Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fat tissue secrets in kidney disease revealed?

NCT ID NCT02902705

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study looked at fat tissue in 23 men with advanced chronic kidney disease (stage V) who were not on dialysis. Researchers compared their fat cells to those of healthy men to understand why kidney disease causes problems like weight loss and insulin resistance. Fat samples were taken during planned surgeries and analyzed for cell size and gene activity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

23 people

The number who actually took part.

Start date

Sep 2009

Finished

Jul 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: CKD (Chronic Kidney Disease) and non-CKD patients: * At least 18 years of age * Able and willing to provide informed consent * Male gender * Normal fasting glucose (less than 6 mmol/l ) * No evidence of significant concurrent illness * BMI \<30 kg/m2 * Non acidotic (bicarbonate \>20 mmol/L) * Normal coagulation profile CKD patients: • eGFR (estimated Glomerular Filtration Rate)\< 25 mL/min/m2 before the beginning of renal suppletion therapy Non-CKD patients: • eGFR \>50 mL/min/m2 Exclusion Criteria: * A known diagnosis of diabetes mellitus * enrolled in a other study that may confound results of this study. * Have been treated with: corticosteroids or insulin or oral diabetic medications within 8 days prior to study entry * Unwilling and/or not able to give written consent * Patient with active systemic bacterial, viral or fungal infections

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease - stage V are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure uremia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease - stage V

Contacts and locations

Locations

  • Service de Néphrologie, dialyse, hypertension artérielle - Pavillon P - Hôpital Edouard Herriot -

    Lyon, 69003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.